UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (date of earliest event reported): March 19, 2012
DEHAIER MEDICAL SYSTEMS LIMITED
(Exact name of registrant as specified in its charter)
| British Virgin Islands | 001-34661 | Not Applicable | ||
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
Suite 501, Jiuzhou Plaza
83 Fuxing Road, Haidian District
Beijing 100856 China
(Address of principal executive offices, including zip code)
+86 (10) 5166-0080
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| £ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| £ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| £ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| £ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
On March 19, 2012, the Registrant issued a press release announcing its 2011 fourth quarter and year end financial results. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
| Number | Description of Exhibit | |
| 99.1 | Press release dated March 19, 2012 titled “Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results.” |
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Dehaier Medical Systems Limited | |||
| By: | /s/ Ping Chen | ||
| Ping Chen | |||
| Chief Executive Officer | |||
Dated: March 20, 2012